Dymon Asia Capital (Singapore) Pte. Ltd.
Source: SEC Form 13F · as of Mar 2026Dymon Asia Capital (Singapore) Pte. Ltd. holds 21 biotech & pharma companies tracked by BioSniper, totaling $48.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$48.5M
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 50,000 | $13.5M |
| GILDGILEAD SCIENCES, INC. | 30,000 | $4.2M |
| IQVIQVIA Holdings Inc. | 21,000 | $3.6M |
| AZNASTRAZENECA PLC | 18,000 | $3.5M |
| JNJJOHNSON & JOHNSON | 14,400 | $3.5M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 60,200 | $3.3M |
| NVSNovartis AG | 20,000 | $3.1M |
| TEVATeva Pharmaceutical Industries Limited | 100,000 | $3.0M |
| BIIBBIOGEN INC. | 15,000 | $2.7M |
| BNTXBioNTech SE | 21,000 | $1.9M |
| MRKMerck & Co., Inc. | 10,000 | $1.2M |
| COGTCogent Biosciences, Inc. | 22,700 | $874K |
| UTHRUNITED THERAPEUTICS Corp | 1,460 | $866K |
| DNTHDianthus Therapeutics, Inc. /DE/ | 7,600 | $638K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 11,000 | $621K |
| IMVTImmunovant, Inc. | 23,805 | $591K |
| PTGXProtagonist Therapeutics, Inc | 4,600 | $485K |
| BLTEBELITE BIO, INC | 1,900 | $303K |
| SVRASavara Inc | 46,000 | $251K |
| NBPNovaBridge Biosciences | 80,400 | $198K |
| ANLAdlai Nortye Ltd. | 15,000 | $104K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.